InSphero AG:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:InSphero AG - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10437
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InSphero AG (InSphero) is a biotechnology company that offers production, culture and assessment of organotypic 3D cell culture models. The company’s product portfolio includes microtissues kits, cytotoxicity assay kits, and microtissue spheroids, among others. Its patented 3D cell culture platforms and methods enable production of assay-ready 3D InSight microtissues derived from liver, pancreas, tumor, heart, brain and skin. InSphero offers services such as in vitro toxicology, diabetes and nash drug discovery, and oncology drug discovery. The company’s models and research services identifies drugs and toxic liabilities at early development stages. It operates in Switzerland, the US and Germany. InSphero is headquartered in Schlieren, Switzerland.

InSphero AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
InSphero AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
InSphero AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
InSphero AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
InSphero AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
InSphero AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
InSphero AG, Medical Equipment, Deal Details 10
Venture Financing 10
InSphero Raises USD10 Million in Financing 10
InSphero Raises US$2.1 Million In Series B Financing 11
Partnerships 12
InSphero to Enter into Licensing Agreement with Charles River Labs 12
InSphero Enters into Partnership with ALPCO 13
InSphero Enters into Licensing Agreement with National Center for Advancing Translational Sciences 14
InSphero Enters into Agreement with Pfizer 15
Protea Biosciences Enters into Agreement with InSphero for 3D Technologies 16
Cyprotex Enters Into Agreement With InSphero For New 3D Microtissue Service 17
Acquisition 18
Redalpine Venture Partners Sells Interest in InSphero 18
InSphero AG – Key Competitors 19
InSphero AG – Key Employees 20
InSphero AG – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Strategy And Business Planning 22
Jun 11, 2018: InSphero Partners with ALPCO to Advance Diabetes Research 22
Product News 23
Apr 03, 2017: Novel 3D Cell-based Assays Accelerate Discovery for Immuno-oncology/CAR-T Therapies 23
Feb 02, 2017: InSphero to Introduce GravityTRAP 384 Microtissue Platform at SLAS2017 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
InSphero AG, Medical Equipment, Key Facts 2
InSphero AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
InSphero AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
InSphero AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
InSphero AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
InSphero AG, Deals By Market, 2012 to YTD 2018 8
InSphero AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
InSphero Raises USD10 Million in Financing 10
InSphero Raises US$2.1 Million In Series B Financing 11
InSphero to Enter into Licensing Agreement with Charles River Labs 12
InSphero Enters into Partnership with ALPCO 13
InSphero Enters into Licensing Agreement with National Center for Advancing Translational Sciences 14
InSphero Enters into Agreement with Pfizer 15
Protea Biosciences Enters into Agreement with InSphero for 3D Technologies 16
Cyprotex Enters Into Agreement With InSphero For New 3D Microtissue Service 17
Redalpine Venture Partners Sells Interest in InSphero 18
InSphero AG, Key Competitors 19
InSphero AG, Key Employees 20
InSphero AG, Subsidiaries 21

List of Figures
InSphero AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
InSphero AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
InSphero AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
InSphero AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
InSphero AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
InSphero AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
InSphero AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
InSphero AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[InSphero AG:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Actividades de Construccion y Servicios SA:戦略・SWOT・企業財務分析
    Actividades de Construccion y Servicios SA - Strategy, SWOT and Corporate Finance Report Summary Actividades de Construccion y Servicios SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Aspyrian Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aspyrian Therapeutics Inc (Aspyrian Therapeutics) is a biotechnology company which develops precision targeted medicines to handle both the primary tumor and systemic disease. Its lead pipeline product, RM-1929, is under development for the treatment of different cancer types, including canc …
  • Bumi Armada Bhd (ARMADA):石油・ガス:M&Aディール及び事業提携情報
    Summary Bumi Armada Bhd (Bumi Armada) is an integrated offshore solutions provider. The company owns and operates Floating Production Storage & Offloading (FPSO), Offshore Support Vessels (OSV), pipelaying barges, and subsea vessels. Its FPSO portfolio includes Armada TGT 1, Armada Sterling, Armada …
  • Melinta Therapeutics Inc (MLNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Melinta Therapeutics Inc (Melinta) is a biopharmaceutical company that focuses on the development of novel antibiotics. Its drugs are intended to treat the various bacterial infections. The company's lead product Baxdela (delafloxacin) has been approved by the US FDA as an IV treatment for s …
  • Amazon.com, Inc.:企業の戦略・SWOT・財務情報
    Amazon.com, Inc. - Strategy, SWOT and Corporate Finance Report Summary Amazon.com, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ferguson Plc:企業のM&A・事業提携・投資動向
    Ferguson Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ferguson Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Marafiq:発電所・企業SWOT分析
    Marafiq - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives …
  • Spark Therapeutics Inc (ONCE):製薬・医療:M&Aディール及び事業提携情報
    Summary Spark Therapeutics Inc (Spark) is a clinical-stage gene therapy company which provides gene therapies for inherited retinal diseases (IRDs), neurodegenerative diseases, as well as liver diseases. Its pipeline products include SPK-RPE65, SPK-CHM, rhonova, LHON, SPK-FIX, SPK-FVIII and SPK-TPP1 …
  • TC Pipelines LP (TCP):企業の財務・戦略的SWOT分析
    Summary TC Pipelines LP (TC Pipelines) is an oil and gas company that manages natural gas pipelines and related assets. The company offers development and operation of North American energy infrastructure including natural gas and liquids pipelines, power generation and gas storage facilities. It op …
  • LIXIL Group Corporation:企業の戦略・SWOT・財務分析
    LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report Summary LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Flexion Therapeutics Inc (FLXN):企業の財務・戦略的SWOT分析
    Flexion Therapeutics Inc (FLXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Hongkong Land Holdings Ltd
    Hongkong Land Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Hongkong Land Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Sumitomo Heavy Industries Ltd (6302):企業の財務・戦略的SWOT分析
    Sumitomo Heavy Industries Ltd (6302) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Endo Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Endo Pharmaceuticals Inc (Endo Pharmaceuticals), a subsidiary of Endo International plc is a healthcare products provider that offers medicinal products. The company manufactures and distributes generic pharmaceutical products and over-the-counter medications. Its products include testostero …
  • James Fisher and Sons Plc (FSJ)-石油・ガス分野:企業M&A・提携分析
    Summary James Fisher and Sons plc (James Fisher) is a service provider that focuses on global marine industry and a specialist supplier of engineering services to the energy industry. The company provides comprehensive services such as design and engineering; inspection and monitoring; lifting and h …
  • Electricity Supply Board-エネルギー分野:企業M&A・提携分析
    Summary Electricity Supply Board (ESB) owned by Irish Government, is a diversified and vertically integrated utility that generates, transmits, and distributes and supplies electricity and gas. The company builds, owns and maintains transmission and distribution networks. It offers meter reading, an …
  • NEC Networks & System Integration Corp (1973):企業の財務・戦略的SWOT分析
    NEC Networks & System Integration Corp (1973) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Summit Midstream Partners LP (SMLP):企業の財務・戦略的SWOT分析
    Summary Summit Midstream Partners LP (SMLP) is an oil and gas company that develops, owns and operates midstream energy infrastructure assets located in unconventional shale resource basins and shale formations across North America. The company operates natural gas, crude oil, and produced water gat …
  • Nu Skin Enterprises, Inc.:企業の戦略・SWOT・財務情報
    Nu Skin Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nu Skin Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Avisa Pharma Inc:製品パイプライン分析
    Summary Avisa Pharma Inc (Avisa Pharma) is a medical device company that develops breath tests system for the diagnosis of pulmonary infections. The company’s product include avisa breath test kit, which is designed to detect respiratory bacterial infections in the lung and other metabolic diseases; …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆